
Dual-action GLP‑1/GIP for faster results
- From
- $149/mo
- Taken
- Once-weekly injection
- Type
- Dual GLP‑1/GIP agonist
Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Arbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who decide whether treatment is appropriate. Compounded medications are prepared by licensed U.S. pharmacies for individual patients and are not reviewed by the FDA for safety or effectiveness.
Sources
- Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Front Aging Neurosci. 2019;11:257.
- Reyna K, Heinzen G, Patel N, et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026;7:1652582.
- Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026;116:103057.
- U.S. Food and Drug Administration. FDA reminds compounders to use ingredients suitable for sterile compounding. October 30, 2024.
- U.S. Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act (categories 1, 2 and 3). Updated May 14, 2026.
- U.S. Food and Drug Administration. Amendments to the list of bulk drug substances that can be used to compound drug products in accordance with section 503A. Proposed rule. Federal Register, September 5, 2019.
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers.
- Abolfotouh MA, Salam M, Bani-Mustafa A, White D, Balkhy HH. Prospective study of incidence and predictors of peripheral intravenous catheter-induced complications. Ther Clin Risk Manag. 2014;10:993-1001.
Keep reading
All 150 articles →- Longevity
Glutathione vs NAC: Taking the Antioxidant Directly vs Taking Its Building Block
One is the antioxidant itself. The other is the raw material your cells use to make it. Here is how they compare, and why our clinicians prescribe glutathione itself.
By Arbor Health Team
- Longevity
Glutathione Injections vs Liposomal Glutathione Supplements: What Your Body Actually Absorbs
A liposomal supplement and a compounded injection put the same molecule into the body by very different roads. Here is what each has been shown to do, where the evidence stops, and how our clinicians weigh the two.
By Arbor Health Team
- Longevity
NAD+ vs Glutathione: What Each Does & Why People Take Both
Both are molecules your cells make, both fall with age, and both are sold as at-home injections. They do different jobs. Here is what each one does, what the evidence can and cannot say, and how the two connect.
By Arbor Health Team







